Today: 22 May 2026
Paymentus stock ends first 2026 session down nearly 10% — what’s behind the sudden drop?
4 January 2026
2 mins read

Paymentus stock ends first 2026 session down nearly 10% — what’s behind the sudden drop?

New York, Jan 3, 2026, 20:13 ET — Market closed

  • Paymentus Holdings (PAY) closed down 9.9% at $28.47 in Friday’s session.
  • The move outpaced several payments peers, with Bill Holdings down 7.3% while Affirm and Shift4 fell about 0.5% each.
  • Traders are looking to early-January U.S. data — especially jobs and inflation — for the next signal on rate-cut expectations.

Paymentus Holdings’ shares tumbled nearly 10% in the first U.S. trading session of 2026, ending Friday at $28.47. The stock traded as low as $28.22 intraday.

The outsized move lands as investors shift positioning ahead of a busy January calendar that can reset interest-rate bets, a key driver for high-growth stocks. The monthly jobs report due Jan. 9 and the consumer price index on Jan. 13 are among the headline events, Reuters reported.

“The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, told Reuters. Rate expectations often matter more for growth names because lower borrowing costs generally lift the value investors assign to future earnings. Reuters

The broad market did not mirror Paymentus’ selloff. The Dow and S&P 500 ended higher on Friday, while the Nasdaq was essentially flat, according to Reuters.

Paymentus opened at $31.43 and hit $31.63 before the selloff accelerated, market data showed. About 1.4 million shares traded — above the stock’s average daily volume of roughly 771,000 shares, according to FinViz.

A Nasdaq technical alert flagged Paymentus as “oversold” after its 14-day Relative Strength Index (RSI) fell to 29.9. RSI is a momentum gauge some traders use to judge whether selling pressure is becoming stretched. Nasdaq

Paymentus sells cloud-based bill payment technology used by billers and financial institutions across utilities, insurance, government, telecommunications and healthcare. The company says it processed more than 597 million payments in 2024 and distributes services through its Instant Payment Network.

The company’s most recent results, reported in November, showed third-quarter revenue of $310.7 million, up 34.2% from a year earlier, and adjusted EBITDA of $35.9 million, up 45.9%. Paymentus also issued fourth-quarter revenue guidance of $307 million to $312 million and full-year 2025 revenue guidance of $1.173 billion to $1.178 billion.

Friday’s decline also outpaced several payments and fintech peers. Bill Holdings fell 7.3%, while Shift4 Payments and Affirm ended down about half a percent each, market data showed.

U.S. markets reopen on Monday, Jan. 5, with investors watching how Treasury yields react as the jobs report approaches. Reuters reported the employment data due Jan. 9 could move rate expectations after the Federal Reserve lowered rates at each of its last three meetings of 2025.

Reuters reported fed funds futures point to little chance of a cut at the late-January Fed meeting, while implying close to a 50% probability of a quarter-point reduction in March. That setup can keep volatility elevated for rate-sensitive growth stocks.

For Paymentus, the next clear company catalyst is earnings. The company has not confirmed its next report date; MarketChameleon estimates results between March 3 and March 10, while MarketBeat pegs an estimated date around March 9 based on prior-year timing.

Technically, traders are likely to focus on Friday’s low of $28.22 as near-term support and the $31.63 session high as a first resistance level. The RSI “oversold” signal suggests selling may be stretched, but the stock’s direction is likely to hinge on whether it can hold that low when liquidity returns next week. Nasdaq

More broadly, investors are balancing valuation concerns against earnings expectations as fourth-quarter reporting season nears, Reuters reported. For Paymentus specifically, attention is likely to center on transaction growth and margins against the company’s latest guidance.

Stock Market Today

  • TD Cowen Keeps Hold Rating on Atmos Energy, Raises Price Target to $196
    May 22, 2026, 9:21 AM EDT. TD Cowen maintains a Hold rating on Atmos Energy (ATO) as of October 3, 2023. The price target is raised slightly by 1.55%, from $193 to $196. This move indicates moderate confidence in ATO's near-term prospects but advises investors to hold rather than buy or sell the stock.

Latest articles

Atmos Energy’s Texas Growth Story Just Ran Into a Wall Street Target Cut

Atmos Energy’s Texas Growth Story Just Ran Into a Wall Street Target Cut

22 May 2026
Morgan Stanley lowered its Atmos Energy price target to $183 from $195, maintaining an Equalweight rating. The move follows Atmos’ recent increase in its 2026 earnings outlook and annual dividend. Atmos shares closed at $177.46 on Thursday. Texas remains central to Atmos’ growth and regulatory strategy, with 65% of its rate base in the state.
Strive Stock’s Bitcoin Play Grows, Traders Eye the Open

Strive Stock’s Bitcoin Play Grows, Traders Eye the Open

22 May 2026
Strive Inc.’s Class A shares traded at $19.24 in Friday premarket, up from Thursday’s $18.53 close, after the company disclosed it bought 381.61 bitcoin last week, raising its total to 15,391 coins. Strive reported $87.3 million in cash and $49.8 million in Strategy Inc. preferred stock as of May 18. SATA preferred dividends will shift to daily payments starting June 16. U.S. equity markets close Monday for Memorial Day.
Walmart stock falls with investors eyeing the gas pump

Walmart stock falls with investors eyeing the gas pump

22 May 2026
Walmart shares fell 7.3% to $121.34 Thursday, their steepest drop since 2023, after first-quarter results showed rising revenue but warned of pressure from higher fuel costs. The company reported $177.8 billion in revenue and 4.1% comparable U.S. sales growth, but investors reacted to slowing trends and margin concerns. Walmart kept its full-year outlook unchanged.
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus
Previous Story

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Intel stock jumps 6.7% to start 2026 as chip rally returns — what investors watch next
Next Story

Intel stock jumps 6.7% to start 2026 as chip rally returns — what investors watch next

Go toTop